Aurinia Pharmaceuticals Inc.
NasdaqGM:AUPH
$ 4.91
$0.00 (0.00%)
$ 4.91
$0.00 (0.00%)
End-of-day quote: 04/26/2024

AUPH - Aurinia Pharmaceuticals Stock Prediction 2025 - 2030

12 years of reliable Aurinia Pharmaceuticals stock forecast. The Wall Street analysts predict Outperform for AUPH. See at a glance whether NasdaqGM:AUPH will rise in the future.

$0.00
Forecast 2023
$5.71
Forecast 2025
$8.93
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$5.71
Forecast 2030
$8.93
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.38
Price-to-book Ratio
1.87
Market Cap
0.85B
TEV
0.59 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$13.21
Country

Aurinia Pharmaceuticals Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Aurinia Pharmaceuticals Stock Forecast 2023

$10.00

In the last five quarters, Aurinia Pharmaceuticals’s Price Target has fallen from $26.63 to $13.21 - a -50.39% decrease. Six analysts predict that Aurinia Pharmaceuticals’s share price will fall in the coming year, reaching $10.00. This would represent a decrease of -24.3%.

103.67%
103.67
Last update: 04/29/2024

Highest Price Target $15.00

Average Price Target $10.00

Lowest Price Target $8.00

Aurinia Pharmaceuticals Stock Forecast 2025

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Jan 2025.

In Jan 2025 analysts predict a share price of $5.26. An increase of 7.12% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Feb 2025.

In Feb 2025 analysts predict a share price of $5.30. An increase of 7.95% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Mar 2025.

In Mar 2025 analysts predict a share price of $5.34. An increase of 8.78% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Apr 2025.

In Apr 2025 analysts predict a share price of $5.38. An increase of 9.61% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in May 2025.

In May 2025 analysts predict a share price of $5.42. An increase of 10.44% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Jun 2025.

In Jun 2025 analysts predict a share price of $5.46. An increase of 11.27% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Jul 2025.

In Jul 2025 analysts predict a share price of $5.50. An increase of 12.1% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Aug 2025.

In Aug 2025 analysts predict a share price of $5.54. An increase of 12.93% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Sep 2025.

In Sep 2025 analysts predict a share price of $5.59. An increase of 13.76% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Oct 2025.

In Oct 2025 analysts predict a share price of $5.63. An increase of 14.59% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Nov 2025.

In Nov 2025 analysts predict a share price of $5.67. An increase of 15.42% compared to today's share price.

Stock Prediction for the Price of One Aurinia Pharmaceuticals Share in Dec 2025.

In Dec 2025 analysts predict a share price of $5.71. An increase of 16.24% compared to today's share price.

Aurinia Pharmaceuticals Stock Predictions 2030

Aurinia Pharmaceuticals Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $8.23. An increase of 67.56% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $8.29. An increase of 68.86% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $8.35. An increase of 70.16% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $8.42. An increase of 71.45% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $8.48. An increase of 72.75% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $8.55. An increase of 74.05% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $8.61. An increase of 75.35% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $8.67. An increase of 76.64% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $8.74. An increase of 77.94% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $8.80. An increase of 79.24% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $8.86. An increase of 80.53% compared to the previous month's estimate.

Aurinia Pharmaceuticals Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $8.93. An increase of 81.83% compared to the previous month's estimate.

P/E
0.00
Beta
1.38
Price-to-book Ratio
1.87
Market Cap
0.85B
TEV
0.59 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$13.21
Country

Aurinia Pharmaceuticals Analyst Ratings Frequently Asked Questions

Who are the analysts watching Aurinia Pharmaceuticals Inc.?

The following analysts have recently covered Aurinia Pharmaceuticals:

Bloom Burton & Co.
Cantor Fitzgerald & Co.
H.C. Wainwright & Co.
Jefferies LLC
Leerink Partners LLC
Marktfeld
RBC Capital Markets
TD Cowen
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Aurinia Pharmaceuticals Inc.?

The following sell-side analysts have recently covered Aurinia Pharmaceuticals:

Martin, David C.
Brayer, Olivia Simone
Arce, Antonio Eduardo
Raycroft, Maurice Thomas
Schwartz, Joseph Patrick
Paraskevopoulos, Michail
Miehm, Douglas
Ku, Stacy
(This information refers to the last 90 days.)